Access to innovation is critical in the fast-paced world of R&D – but outsourcing scientific services and working with new labs is typically fraught with risk. The resulting sourcing, QA, contracting, and financial processes have created administrative burdens that too often distract scientists and prevent access to innovation. During this session, we will share market-level data on roadblocks to outsourcing efficiency and look into case studies that entails researchers\’ recent successes streamlining access to innovative technologies through outsourcing.

ABOUT THE SPEAKER

Dr. Elizabeth Iorns is the Founder & CEO of Science Exchange, the Co-Director of the Reproducibility Initiative, and is a part-time partner at Y Combinator. Elizabeth has a Ph.D. in Cancer Biology from the Institute of Cancer Research (UK), and before starting Science Exchange in 2011 was an Assistant Professor at the University of Miami (where she remains an Adjunct Professor). Elizabeth has received a range of honors and recognition, including the Kauffman Foundation Emerging Entrepreneur Award, one of Nature Magazine’s ‘Ten People Who Mattered’, and one of WIRED’s \’50 Women Who Are Changing The World\’. Elizabeth is focused on the development of innovative models to promote the quality and efficiency of scientific research.